Join us at PCC 2026, the premier compliance conference for the pharmaceutical industry, where leading pharma compliance professionals and senior compliance officers will share their expertise. Our speakers, exclusively from life science compliance and legal departments, will lead thought-provoking discussions on pharmaceutical compliance, pharma ethics, and regulatory excellence. This event is designed to empower life sciences professionals with actionable insights and innovative strategies to achieve compliance excellence and uphold ethical standards in the pharmaceutical industry.
Partner Dominick DiSabatino will be speaking on the panel "Best Practice for Investigations, Whistleblower Incentives & Protections" on April 27 from 2:15-3:00 PM.
Panel Discussion Topics:
- New ideas and solutions to investigator challenges
- Practical tools and tips for handling difficult investigations and joint working with Legal/HR
- How are investigation outcomes shared with the organization?
- Providing clear, C-suite-endorsed messaging that encourages internal reporting
- Strengthening internal complaint pathways in addition to anonymous reporting options
- Approaches for responding to hotline reporters
Partner Scott Liebman will be speaking on the panel "Law Firm Benchmarking Session - Chairs of Life Science Groups in Law Firms" on April 28 from 12:00-12:50 PM.
Panel Discussion Topics:
- Analysis of the most recent Executive Orders impacting (Bio)pharmaceutical companies
- Implications of the Big, Beautiful Bill and Most Favoured Nations Pricing
- Update on FDA activity
- Litigation against the Administration